Linking non-coding genetic variants associated with the risk of diseases or disease-relevant traits to target genes is a crucial step to realize GWAS potential in the introduction of precision medicine. Here we set out to determine the mechanisms underpinning variant association with platelet quantitative traits using cell type-matched epigenomic data and promoter long-range interactions. We identify potential regulatory functions for 423 of 565 (75%) non-coding variants associated with platelet traits and we demonstrate, through ex vivo and proof of principle genome editing validation, that variants in super enhancers play an important role in controlling archetypical platelet functions.status: publishe
Platelet aggregation at the site of atherosclerotic vascular injury is the underlying pathophysiolog...
Platelet aggregation at the site of atherosclerotic vascular injury is the underlying pathophysiolog...
Platelet aggregation at the site of atherosclerotic vascular injury is the underlying pathophysiolog...
Linking non-coding genetic variants associated with the risk of diseases or disease relevant traits ...
Linking non-coding genetic variants associated with the risk of diseases or disease-relevant traits ...
Linking non-coding genetic variants associated with the risk of diseases or disease-relevant traits ...
Linking non-coding genetic variants associated with the risk of diseases or disease-relevant traits ...
Linking non-coding genetic variants associated with the risk of diseases or disease-relevant traits ...
Platelets are the second most abundant cell type in blood and are essential for maintaining haemosta...
Platelets are the second most abundant cell type in blood and are essential for maintaining haemosta...
Platelets are the second most abundant cell type in blood and are essential for maintaining haemosta...
Platelets are the second most abundant cell type in blood and are essential for maintaining haemosta...
Platelets are the second most abundant cell type in blood and are essential for maintaining haemosta...
Platelets are the second most abundant cell type in blood and are essential for maintaining haemosta...
Variations in platelet number, volume and function are largely genetically controlled and many loci ...
Platelet aggregation at the site of atherosclerotic vascular injury is the underlying pathophysiolog...
Platelet aggregation at the site of atherosclerotic vascular injury is the underlying pathophysiolog...
Platelet aggregation at the site of atherosclerotic vascular injury is the underlying pathophysiolog...
Linking non-coding genetic variants associated with the risk of diseases or disease relevant traits ...
Linking non-coding genetic variants associated with the risk of diseases or disease-relevant traits ...
Linking non-coding genetic variants associated with the risk of diseases or disease-relevant traits ...
Linking non-coding genetic variants associated with the risk of diseases or disease-relevant traits ...
Linking non-coding genetic variants associated with the risk of diseases or disease-relevant traits ...
Platelets are the second most abundant cell type in blood and are essential for maintaining haemosta...
Platelets are the second most abundant cell type in blood and are essential for maintaining haemosta...
Platelets are the second most abundant cell type in blood and are essential for maintaining haemosta...
Platelets are the second most abundant cell type in blood and are essential for maintaining haemosta...
Platelets are the second most abundant cell type in blood and are essential for maintaining haemosta...
Platelets are the second most abundant cell type in blood and are essential for maintaining haemosta...
Variations in platelet number, volume and function are largely genetically controlled and many loci ...
Platelet aggregation at the site of atherosclerotic vascular injury is the underlying pathophysiolog...
Platelet aggregation at the site of atherosclerotic vascular injury is the underlying pathophysiolog...
Platelet aggregation at the site of atherosclerotic vascular injury is the underlying pathophysiolog...